These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2407 related items for PubMed ID: 10878545

  • 1. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y, Yeon J, Kim HJ, Lee ST.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [Abstract] [Full Text] [Related]

  • 6. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T, Yamanouchi K, Sato H, Tojo H, Seiki M, Tachi C.
    Placenta; 2004 Nov 01; 25(10):810-9. PubMed ID: 15451196
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
    Jones JL, Glynn P, Walker RA.
    J Pathol; 1999 Oct 01; 189(2):161-8. PubMed ID: 10547569
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS.
    Cancer Res; 1996 Jan 15; 56(2):384-92. PubMed ID: 8542596
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
    Väisänen A, Tuominen H, Kallioinen M, Turpeenniemi-Hujanen T.
    J Pathol; 1996 Nov 15; 180(3):283-9. PubMed ID: 8958806
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
    Jo M, Thomas LE, Wheeler SE, Curry TE.
    Biol Reprod; 2004 Apr 15; 70(4):1024-32. PubMed ID: 14668206
    [Abstract] [Full Text] [Related]

  • 13. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
    Bérubé M, Deschambeault A, Boucher M, Germain L, Petitclerc E, Guérin SL.
    Mol Vis; 2005 Dec 14; 11():1101-11. PubMed ID: 16379022
    [Abstract] [Full Text] [Related]

  • 14. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP.
    Invasion Metastasis; 1992 Dec 14; 12(3-4):168-84. PubMed ID: 1284126
    [Abstract] [Full Text] [Related]

  • 15. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
    Drew AF, Blick TJ, Lafleur MA, Tim EL, Robbie MJ, Rice GE, Quinn MA, Thompson EW.
    Gynecol Oncol; 2004 Dec 14; 95(3):437-48. PubMed ID: 15581944
    [Abstract] [Full Text] [Related]

  • 16. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
    Docampo MJ, Cabrera J, Rabanal RM, Bassols A.
    Am J Vet Res; 2011 Aug 14; 72(8):1087-96. PubMed ID: 21801067
    [Abstract] [Full Text] [Related]

  • 17. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K, Conway RM, Crouch R, Jager MJ, Madigan MC.
    Exp Eye Res; 2008 Jun 14; 86(6):936-41. PubMed ID: 18423620
    [Abstract] [Full Text] [Related]

  • 18. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
    Hofmann UB, Westphal JR, Van Kraats AA, Ruiter DJ, Van Muijen GN.
    Int J Cancer; 2000 Jul 01; 87(1):12-9. PubMed ID: 10861447
    [Abstract] [Full Text] [Related]

  • 19. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography.
    Kurschat P, Wickenhauser C, Groth W, Krieg T, Mauch C.
    J Pathol; 2002 Jun 01; 197(2):179-87. PubMed ID: 12015741
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H.
    Hum Pathol; 2000 Aug 01; 31(8):895-904. PubMed ID: 10987249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 121.